Allergan Recalls Textured Breast Implants Linked To Rare Type Of Cancer
The Food and Drug Administration, which requested the recall, is not recommending that people who already have Allergan's Biocell implants get them removed unless there are symptoms or problems.
Allergen has announced a global recall of textured breast implants that are linked to a rare type of cancer, at the request of the Food and Drug Administration.
"Biocell saline-filled and silicone-filled textured breast implants and tissue expanders will no longer be distributed or sold in any market where they are currently available," according to a company statement Wednesday.
The FDA said in that while the overall incidence of the cancer appears to be low, it asked Allergan to initiate the Biocell implant recall "once the evidence indicated that a specific manufacturer's product appeared to be directly linked to significant patient harm, including death."
